Progressive IgA Nephropathy Is Associated With Low Circulating Mannan-Binding Lectin–Associated Serine Protease-3 (MASP-3) and Increased Glomerular Factor H–Related Protein-5 (FHR5) Deposition

McGrogan, 2011, The incidence of primary glomerulonephritis worldwide: a systematic review of the literature, Nephrol Dial Transplant, 26, 414, 10.1093/ndt/gfq665

Wyatt, 2013, IgA nephropathy, N Engl J Med, 368, 2402, 10.1056/NEJMra1206793

Jennette, 1988, The immunohistology of IgA nephropathy, Am J Kidney Dis, 12, 348, 10.1016/S0272-6386(88)80022-2

Lai, 2012, Pathogenesis of IgA nephropathy, Nat Rev Nephrol, 8, 275, 10.1038/nrneph.2012.58

Knoppova, 2016, The origin and activities of IgA1-containing immune complexes in IgA nephropathy, Front Immunol, 7, 117, 10.3389/fimmu.2016.00117

D'Amico, 2004, Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome, Semin Nephrol, 24, 179, 10.1016/j.semnephrol.2004.01.001

Rauen, 2015, Intensive supportive care plus immunosuppression in IgA nephropathy, N Engl J Med, 373, 2225, 10.1056/NEJMoa1415463

Maillard, 2015, Current understanding of the role of complement in IgA nephropathy, J Am Soc Nephrol, 26, 1503, 10.1681/ASN.2014101000

Zwirner, 1997, Activated complement C3: a potentially novel predictor of progressive IgA nephropathy, Kidney Int, 51, 1257, 10.1038/ki.1997.171

Kim, 2012, Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy, PLoS One, 7

Medjeral-Thomas, 2017, Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy, Kidney Int, 92, 942, 10.1016/j.kint.2017.03.043

Tortajada, 2017, Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy, Kidney Int, 92, 953, 10.1016/j.kint.2017.03.041

Kjaer, 2013, Toward a structure-based comprehension of the lectin pathway of complement, Mol Immunol, 56, 413, 10.1016/j.molimm.2013.05.007

Miyazaki, 1984, Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy, Clin Nephrol, 21, 335

Wyatt, 1987, Complement activation in IgA nephropathy, Kidney Int, 31, 1019, 10.1038/ki.1987.101

Berthoux, 2012, Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy, J Am Soc Nephrol, 23, 1579, 10.1681/ASN.2012010053

Thiel, 2007, Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins, Mol Immunol, 44, 3875, 10.1016/j.molimm.2007.06.005

Roos, 2001, Human IgA activates the complement system via the mannan-binding lectin pathway, J Immunol, 167, 2861, 10.4049/jimmunol.167.5.2861

Guo, 2017, Mannose-binding lectin levels could predict prognosis in IgA nephropathy, J Am Soc Nephrol, 28, 3175, 10.1681/ASN.2017010076

Roos, 2006, Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease, J Am Soc Nephrol, 17, 1724, 10.1681/ASN.2005090923

Espinosa, 2014, Association of C4d deposition with clinical outcomes in IgA nephropathy, Clin J Am Soc Nephrol, 9, 897, 10.2215/CJN.09710913

Roberts, 2009, The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility, Kidney Int, 76, 546, 10.1038/ki.2009.168

Levey, 2009, A new equation to estimate glomerular filtration rate, Ann Intern Med, 150, 604, 10.7326/0003-4819-150-9-200905050-00006

Thiel, 2002, Assays for the functional activity of the mannan-binding lectin pathway of complement activation, Immunobiology, 205, 446, 10.1078/0171-2985-00145

Wittenborn, 2010, Characteristics and biological variations of M-ficolin, a pattern recognition molecule, in plasma, J Innate Immun, 2, 167

Krarup, 2005, Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin, Infect Immun, 73, 1052, 10.1128/IAI.73.2.1052-1060.2005

Axelgaard, 2013, Investigations on collectin liver 1, J Biol Chem, 288, 23407, 10.1074/jbc.M113.492603

Selman, 2012, An enzyme-linked immunosorbent assay (ELISA) for quantification of human collectin 11 (CL-11, CL-K1), J Immunol Methods, 375, 182, 10.1016/j.jim.2011.10.010

Troldborg, 2015, Collectin liver 1 and collectin kidney 1 and other complement-associated pattern recognition molecules in systemic lupus erythematosus, Clin Exp Immunol, 182, 132, 10.1111/cei.12678

Moller-Kristensen, 2003, Levels of mannan-binding lectin-associated serine protease-2 in healthy individuals, J Immunol Methods, 282, 159, 10.1016/j.jim.2003.08.012

Degn, 2010, Biological variations of MASP-3 and MAp44, two splice products of the MASP1 gene involved in regulation of the complement system, J Immunol Methods, 361, 37, 10.1016/j.jim.2010.07.006

Degn, 2011, MAp19, the alternative splice product of the MASP2 gene, J Immunol Methods, 373, 89, 10.1016/j.jim.2011.08.006

Lomax-Browne, 2017, IgA1 glycosylation is heritable in healthy twins, J Am Soc Nephrol, 28, 64, 10.1681/ASN.2016020184

Benjamini, 2006, Adaptive linear step-up procedures that control the false discovery rate, Biometrika, 93, 491, 10.1093/biomet/93.3.491

Liu, 2005, Human M-ficolin is a secretory protein that activates the lectin complement pathway, J Immunol, 175, 3150, 10.4049/jimmunol.175.5.3150

Troldborg, 2017, Lectin complement pathway proteins in healthy individuals, Clin Exp Immunol, 188, 138, 10.1111/cei.12909

Lu, 1996, Human ficolin: cDNA cloning, demonstration of peripheral blood leucocytes as the major site of synthesis and assignment of the gene to chromosome 9, Biochem J, 313, 473, 10.1042/bj3130473

Thiel, 1992, The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response, Clin Exp Immunol, 90, 31, 10.1111/j.1365-2249.1992.tb05827.x

Endo, 2011, The role of ficolins in the lectin pathway of innate immunity, Int J Biochem Cell Biol, 43, 705, 10.1016/j.biocel.2011.02.003

Thiel, 2012, Mannan-binding lectin (MBL)-associated serine protease-1 (MASP-1), a serine protease associated with humoral pattern-recognition molecules: normal and acute-phase levels in serum and stoichiometry of lectin pathway components, Clin Exp Immunol, 169, 38, 10.1111/j.1365-2249.2012.04584.x

Degn, 2011, Disease-causing mutations in genes of the complement system, Am J Hum Genet, 88, 689, 10.1016/j.ajhg.2011.05.011

Troldborg, 2015, Levels in plasma of the serine proteases and associated proteins of the lectin pathway are altered in patients with systemic lupus erythematosus, J Rheumatol, 42, 948, 10.3899/jrheum.141163

Tanha, 2017, Plasma ficolin levels and risk of nephritis in Danish patients with systemic lupus erythematosus, Clin Rheumatol, 36, 335, 10.1007/s10067-016-3508-2

Watanabe, 2012, Serum L-ficolin levels in patients with systemic lupus erythematosus, Mod Rheumatol, 22, 899, 10.3109/s10165-012-0616-y

Matsushita, 2013, Ficolins in complement activation, Mol Immunol, 55, 22, 10.1016/j.molimm.2012.08.017

Heja, 2012, Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2, Proc Natl Acad Sci U S A, 109, 10498, 10.1073/pnas.1202588109

Iwaki, 2006, Small mannose-binding lectin-associated protein plays a regulatory role in the lectin complement pathway, J Immunol, 177, 8626, 10.4049/jimmunol.177.12.8626

Zundel, 2004, Characterization of recombinant mannan-binding lectin-associated serine protease (MASP)-3 suggests an activation mechanism different from that of MASP-1 and MASP-2, J Immunol, 172, 4342, 10.4049/jimmunol.172.7.4342

Dobo, 2016, The emerging roles of mannose-binding lectin-associated serine proteases (MASPs) in the lectin pathway of complement and beyond, Immunol Rev, 274, 98, 10.1111/imr.12460

Dahl, 2001, MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway, Immunity, 15, 127, 10.1016/S1074-7613(01)00161-3

Iwaki, 2011, The role of mannose-binding lectin-associated serine protease-3 in activation of the alternative complement pathway, J Immunol, 187, 3751, 10.4049/jimmunol.1100280

Volanakis, 1996, Complement factor D, a novel serine protease, Protein Sci, 5, 553, 10.1002/pro.5560050401

Murphy, 2002, Factor H-related protein-5: a novel component of human glomerular immune deposits, Am J Kidney Dis, 39, 24, 10.1053/ajkd.2002.29873

Paunas, 2017, Glomerular abundance of complement proteins characterized by proteomic analysis of laser-captured microdissected glomeruli associates with progressive disease in IgA nephropathy, Clin Proteomics, 14, 30, 10.1186/s12014-017-9165-x

Goicoechea de Jorge, 2013, Dimerization of complement factor H-related proteins modulates complement activation in vivo, Proc Natl Acad Sci U S A, 110, 4685, 10.1073/pnas.1219260110

Csincsi, 2015, Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation, J Immunol, 194, 4963, 10.4049/jimmunol.1403121

Gale, 2010, Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis, Lancet, 376, 794, 10.1016/S0140-6736(10)60670-8

Medjeral-Thomas, 2014, A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry, Kidney Int, 85, 933, 10.1038/ki.2013.348

Gharavi, 2011, Genome-wide association study identifies susceptibility loci for IgA nephropathy, Nat Genet, 43, 321, 10.1038/ng.787

Zhu, 2015, Variants in complement factor H and complement factor H-related protein genes, CFHR3 and CFHR1, affect complement activation in IgA nephropathy, J Am Soc Nephrol, 26, 1195, 10.1681/ASN.2014010096

Herzog, 2017, First treatment of relapsing rapidly progressive IgA nephropathy with eculizumab after living kidney donation: a case report, Transplant Proc, 49, 1574, 10.1016/j.transproceed.2017.02.044

Ring, 2015, Use of eculizumab in crescentic IgA nephropathy: proof of principle and conundrum?, Clin Kidney J, 8, 489, 10.1093/ckj/sfv076

Rosenblad, 2014, Eculizumab treatment for rescue of renal function in IgA nephropathy, Pediatr Nephrol, 29, 2225, 10.1007/s00467-014-2863-y

Ricklin, 2017, Complement in clinical medicine: clinical trials, case reports and therapy monitoring, Mol Immunol, 89, 10, 10.1016/j.molimm.2017.05.013